Economically, the year 2013 was the most successful in the history of pfm medical. The annual turnover of the Group increased to an all-time high of over 88.5 million euros. The EBIT level once again climbed considerably in comparison with the previous year to reach 6.5 million euros, the highest level ever attained both in absolute terms and in relation to turnover. This excellent result was in part influenced by special items.
With growth at 4.1%, slightly down on the previous year, the Group showed positive development in almost all areas. A major factor in this success is pfm medical’s particular business model, acting as independent manufacturer, exclusive distributor of high quality medical products, technology partner and reliable service provider, all in one. The proportion of turnover generated by the Group’s own products was further increased to around 43.5%.
CEO Aurel Schoeller sees this development as endorsing the company’s strategy of recognising developments at an early stage and creating new system solutions for use in hospital and home-based settings. To quote Schoeller: “In our strategic actions our goal is not just to follow trends but to be active in shaping health care policy.” At the same time pfm medical Institute gGmbH, a non-profit initiative founded in 2009, promotes the academisation of the healthcare and paramedical professions and works to enhance knowledge on topics such as case management and the provision of care across sectors, e.g. by supporting research papers.
pfm medical has also been successful with its internationalisation strategy. The proportion of total Group turnover generated abroad increased again in 2013 to reach a very respectable 43.6%. The strongest foreign growth was achieved in North America and Britain, two key markets for medical technology. This was in part due to marked improvement in the performance of the international subsidiaries. pfm medical is set for growth in the current financial year as well. During the first quarter of 2014 the Group again increased its turnover by around 8 % over the corresponding period in 2013.
With growth at 4.1%, slightly down on the previous year, the Group showed positive development in almost all areas. A major factor in this success is pfm medical’s particular business model, acting as independent manufacturer, exclusive distributor of high quality medical products, technology partner and reliable service provider, all in one. The proportion of turnover generated by the Group’s own products was further increased to around 43.5%.
CEO Aurel Schoeller sees this development as endorsing the company’s strategy of recognising developments at an early stage and creating new system solutions for use in hospital and home-based settings. To quote Schoeller: “In our strategic actions our goal is not just to follow trends but to be active in shaping health care policy.” At the same time pfm medical Institute gGmbH, a non-profit initiative founded in 2009, promotes the academisation of the healthcare and paramedical professions and works to enhance knowledge on topics such as case management and the provision of care across sectors, e.g. by supporting research papers.
pfm medical has also been successful with its internationalisation strategy. The proportion of total Group turnover generated abroad increased again in 2013 to reach a very respectable 43.6%. The strongest foreign growth was achieved in North America and Britain, two key markets for medical technology. This was in part due to marked improvement in the performance of the international subsidiaries. pfm medical is set for growth in the current financial year as well. During the first quarter of 2014 the Group again increased its turnover by around 8 % over the corresponding period in 2013.
